Cargando…
N-acetylcysteine lacks universal inhibitory activity against influenza A viruses
N-acetylcysteine (NAC) has been recently proposed as an adjuvant therapeutic drug for influenza pneumonia in humans. This proposal is based on its ability to restrict influenza virus replication in vitro and to attenuate the severity of the disease in mouse models. Although available studies were ma...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3104374/ https://www.ncbi.nlm.nih.gov/pubmed/21554703 http://dx.doi.org/10.1186/1477-5751-10-5 |